Nxera Pharma Co., Ltd.TSE 4565

ネクセラファーマ株式会社 · Pharmaceutical · FY ends Dec

Share price at FY-end
¥1,048
FY ending Dec 2025 (approx.)
Market cap at FY-end
¥94.8B
Dividend per share
—
Avg. director pay
¥52.2M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 日本マスタートラスト信託銀行株式会社 8,533,800 9.43% ¥8.9B —
2 Daisuke Gomi 7,270,000 8.03% ¥7.6B —
3 JICVGIオポチュニティファンド1号投資事業有限責任組合 5,610,000 6.20% ¥5.9B —
4 CLEARSTREAM BANKING S. A. 3,052,912 3.37% ¥3.2B —
5 BROWN BROTHERS HARRIMAN SCA CUSTODIANFOR ARCUS FUND SICAV - ARCUS JAPAN FUND 2,542,800 2.81% ¥2.7B —
6 ファイザー株式会社 1,885,136 2.08% ¥2.0B —
7 株式会社SBI証券 1,537,549 1.70% ¥1.6B —
8 MSIP Client Securities 1,358,300 1.50% ¥1.4B —
9 BOFAS INC OMNIBUS ACCOUNT 1,212,800 1.34% ¥1.3B —
10 GOLDMAN SACHS INTERNATIONAL 1,079,956 1.19% ¥1.1B —

Officers' holdings and pay

NameTitleSharesValuePay
クリストファー・カーギル Director 131,668 ¥138M —
デビッド・ロブリン Director 12,744 ¥13.4M —
ロルフ・ソダストロム Director 20,525 ¥21.5M —
富田 英子 Director 9,886 ¥10.4M —
志村 直子 Director — — —
ニコラ・ラブソン Director — — —
諸岡 健雄 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 ¥1,048 ¥-262.41 — — 90,496,735
FY ending Dec 2024 ¥1,048 ¥23.89 43.9x — 89,902,858
FY ending Dec 2023 ¥1,048 ¥-39.81 — — 89,446,777
FY ending Dec 2022 — ¥-18.30 456.8x — 81,923,230
FY ending Dec 2021 — ¥-52.47 152.0x — 81,518,316
FY ending Dec 2020 — ¥-16.62 95.9x — 80,596,128
Source: annual securities reports on EDINET. Values are estimates. Methodology